Anumana is a groundbreaking AI-driven health technology firm, specializing in innovations for cardiac care by harnessing electrical signals from the heart to enable early disease detection and improve clinical outcomes. Their portfolio includes advanced algorithms for diagnostic electrocardiography and electrophysiology, aiming to reduce the burden of cardiovascular diseases globally. With a proprietary dataset built from collaborations with premier medical institutions, Anumana's solutions are designed for seamless integration into clinical workflows, providing clinicians the tools needed for timely interventions and enhanced patient safety. The company is focusing on transforming research-grade algorithms into market-ready medical devices and has a strong pipeline of FDA-cleared and designated products.
• early disease detection
• integration with clinical workflows
• improvement in clinical decision support
• portfolio of fda-ready algorithms
• proprietary dataset from leading medical centers
• ai-driven ecg analysis
Average Rating: 0.0
5 Stars:
0 Ratings
4 Stars:
0 Ratings
3 Stars:
0 Ratings
2 Stars:
0 Ratings
1 Star:
0 Ratings
No ratings available.
A federated AI framework that integrates decentralized data sources for AI development.
View Details